سوق المضادات الحيوية - النمو والاتجاهات وتأثير COVID-19 والتوقعات (2023 - 2028)

Market Summary

The antibiotics market was valued at USD 47,150.78 million in 2021, and it is expected to reach USD 63,017.22 million by 2027, registering a CAGR of 5.10% during the forecast period.

The COVID-19 impacted the global supply chain of pharmaceuticals which also impacted the antibiotics market. However, many antibiotics were initially used for the treatment of COVID-19 and widely prescribed and studied as the COVID-19 remedy. For instance, in March 2020, Pfizer announced positive data for the use of its azithromycin (Zithromax) drug, along with hydroxychloroquine, in a coronavirus (COVID-19) clinical trial performed in France. Further, there was a huge demand for antibiotics during the COVID-19 pandemic which also has an impact on the studied market of antibiotics. For instance, according to a July 2021 published article, titled, “Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis”, COVID-19 disease contributed to about 216 million excess doses of non-CAF (child-appropriate formulations) of antibiotics in total and 38 million excess doses of azithromycin between June and September 2020 in India.

The rising prevalence of bacterial infections, coupled with the need for effective and newer antibiotics, is driving the demand for advanced antibiotics. For instance, according to the October 2021 report of the World Health Organization (WHO), about 1.5 million people around the world died because of tuberculosis (TB) in 2020, and approximately 10 million people fell ill with TB, globally. As per the same source from WHO, of the estimated new cases of tuberculosis in 2020, 1.1 million were in children and 86% of the TB cases were reported from the 30 high TB burden countries and one-third of the total cases were reported from eight countries that includes India, China, Indonesia, Philippines, Pakistan, Nigeria, Bangladesh and South Africa.

Furthermore, with the urbanization and destruction of natural habitats, climate change, and changing ecosystems, the rate of emergence of infectious diseases have increased recently and the population group which is primarily affected by these infectious diseases are people of age 65 and more (geriatric population) as they more prone to contracting infection owing to their less responsive immune system and thus, the growing geriatric population around the world is further expect to increase the demand of the antibiotics around the world and augment the growth in the antibiotics market over the forecast period. For instance, as per the World Population Ageing Highlight 2020 report published by the United Nations, the global geriatric population is expected to increase from 727 million in 2020 to 1.5 billion by 2050, which is almost two-fold increase as, the share of geriatric population in 2020 was about 9.3%, which is projected to increase to 16% by 2050. Thus, with the growing ageing population, the burden of infectious diseases is expected to increase which will compliment the growth of the studied market during the forecast period.

Additionally, the emergence of anti-MRSA/VRE drugs, increasing awareness about the infectious diseases and government’s initiatives in improving the availability of antibiotics around the world for various diseases are further expected to augment the growth of the antibiotics market. However, factors such as growing prevalence of antibiotics resistance, regulatory constraints and decreasing number of companies involve in the research of antibiotics are expected to impede the growth of the antibiotics market over the forecast period of the study.

نطاق التقرير

تشير أدوية المضادات الحيوية إلى الأدوية المستخدمة لعلاج الالتهابات عن طريق قتل البكتيريا. هذه من بين أكثر الدورات الموصوفة عالميًا في مكافحة الالتهابات البكتيرية ، وخاصة في العيادات الخارجية. السوق مقسم حسب المنتج (السيفالوسبورينات ، البنسلين ، الفلوروكينولونات ، الماكروليدات ، الكاربابينيمات ، الأمينوغليكوزيدات ، السلفوناميدات ، وأنواع المنتجات الأخرى) ، الطيف (الأجسام المضادة واسعة الطيف والأجسام المضادة ضيقة الطيف) ، والجغرافيا (أمريكا الشمالية ، أوروبا ، آسيا- المحيط الهادئ والشرق الأوسط وأفريقيا وأمريكا الجنوبية). يغطي تقرير السوق أيضًا أحجام واتجاهات السوق المقدرة لـ 17 دولة مختلفة عبر المناطق الرئيسية على مستوى العالم. يقدم التقرير القيمة (بالمليون دولار أمريكي) للقطاعات المذكورة أعلاه.

Report scope can be customized per your requirements. Click here.

اتجاهات السوق الرئيسية

من المتوقع أن تمتلك السيفالوسبورين حصة سوقية كبيرة في سوق المضادات الحيوية خلال فترة التنبؤ

To understand key trends, Download Sample Report